Patents Assigned to SimthKline Beecham p.l.c.
  • Method of treatment of neuropsychiatric symptoms in patients with Alzheimer's Disease
    Patent number: 6750227
    Abstract: The use of [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo[2.2.2]oct-3-yl)acetonitrile or a pharmaceutically acceptable salt thereof for the treatment of neuropsychiatric symptoms in patients with Alzheimer's Disease is disclosed.
    Type: Grant
    Filed: February 21, 2003
    Date of Patent: June 15, 2004
    Assignees: SmithKline Beecham Corporation, SimthKline Beecham p.l.c.
    Inventors: Frank Brown, James P. Mc Cafferty, Eve Naomi Cedar